We are live on
!
Find out more
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP
Delisted
HZNP was delisted on the 5th of October, 2023.
95 hedge funds and large institutions have $347M invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2013 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,391% more call options, than puts
Call options by funds: $11M | Put options by funds: $735K
322% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 9
192% more capital invested
Capital invested by funds: $119M → $347M (+$228M)
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more funds holding
Funds holding: 67 → 95 (+28)
Holders
95
Holders Change
+28
Holders Change %
+41.79%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
38
Increased
32
Reduced
18
Closed
9
Calls
$11M
Puts
$735K
Net Calls
+$10.2M
Net Calls Change
+$6.21M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$25M |
| 2 |
BC
Broadfin Capital
New York
|
+$12.8M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$4.69M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.77M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$3.01M |
